At the hearing, David W. Ogden, a partner with WilmerHale in Washington, D.C., who was testifying on behalf of the U.S. Chamber of Commerce’s Institute for Legal Reform, said companies with certified compliance programs that self report violations should face reduced penalties under the FCA.
Mr. Ogden, who was joined at the hearing by Sen. Chuck Grassley (R-Iowa), also said the FCA should be revised to incentivize organizations to self report violations by removing the threat of future qui tam, or whistle-blower, cases based on the same issue.
More articles on the False Claims Act:
Increased use of non-monetary tools in FCA enforcement
10 recent healthcare industry lawsuits
Government files Anti-Kickback, False Claims lawsuit against Missouri neurosurgeon
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
